TIDMBSFA
RNS Number : 7207N
BSF Enterprise PLC
26 September 2023
FURTHER, THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND
DOES NOT CONSTITUTE OR CONTAIN ANY INVITATION, SOLICITATION,
RECOMMENDATION, OFFER OR ADVICE TO ANY PERSON TO SUBSCRIBE FOR,
OTHERWISE ACQUIRE OR DISPOSE OF ANY SECURITIES IN ANY
JURISDICTION.
26 September 2023
BSF Enterprise plc
("BSF" or the "Company")
Results of General Meeting
Allotment of shares
BSF Enterprise plc (LSE: BSFA), the Main Market listed biotech
company and owner of pioneering UK-based clinical and cellular
agriculture company 3D Bio-Tissues, is pleased to announce that at
the Company's General Meeting held earlier today, all resolutions
proposed were duly passed by shareholders by way of a poll.
Full details of the voting at the General Meeting are set out in
the table below.
Allotment of Shares
As previously announced on 29 March and 12 April 2023, the
Company confirms that it has today allotted 364,739 ordinary
shares, constituting the 264,739 Second Tranche Shares and the
100,000 Financial PR Shares (together, "New Ordinary Shares"),
conditionally on the admission of such New Ordinary Shares to the
Official List by way of a Standard Listing and to trading on the
London Stock Exchange's Main Market for listed securities
("Admission") at the issue price of 17 pence per New Ordinary
Share, 7.25p or 43% above the share price as at 14:00 on 26
September 2023.
Applications have been made to the FCA and to the London Stock
Exchange for the admission of the New Ordinary Shares to the
Official List by way of a Standard Listing and to trading on the
London Stock Exchange's Main Market for listed securities. It is
expected that Admission will become effective at or around 8.00
a.m. on 27 September 2023 and that dealings in the New Ordinary
Shares will commence at that time and that trading in the New
Ordinary Shares will resume at that time.
The New Ordinary Shares will, when issued, be credited as fully
paid and will rank pari passu in all respects with the existing
ordinary Shares of the Company and will on issue be free of all
claims, liens, charges, encumbrances and equities.
Total Voting Rights
The Company confirms that with effect from Admission, the
Company's issued share capital will comprise 103,336,937 ordinary
shares of GBP0.01 each, with each share carrying the right to one
vote. The Company does not hold any ordinary shares in
treasury.
The above figure of 103,336,937 may be used by shareholders as
the denominator for the calculations by which they will determine
if they are required to notify their interest in, or of a change to
their interest in the Company under the FCA's Disclosure and
Transparency Rules.
Results of General Meeting
The resolutions were put to shareholders via a poll, the results
of which were as follows:
Poll Results
Resolution For Against Abstain Discretionary Total
----------- -------- -------- -------------- -----------
1 Shares 45,634,735 162,925 - - 45,797,660
-------- ----------- -------- -------- -------------- -----------
% 99.64% 0.36% - - 100%
-------- ----------- -------- -------- -------------- -----------
2 Shares 45,629,735 167,925 - - 45,797,660
-------- ----------- -------- -------- -------------- -----------
% 99.63% 0.37% - - 100%
-------- ----------- -------- -------- -------------- -----------
The total number of ordinary shares in issue on 26 September
2023 was 102,972,198 shares.
The full text of the resolutions can be found in the Circular
and Notice of General Meeting dated 7 September 2023, which is
available on the Company's website at:
https://www.bsfenterprise.com/investors
In accordance with the UK Listing Authority's Listing Rule
9.6.2, copies of all the resolutions passed by the Company's
shareholders, other than ordinary business will be submitted to the
National Storage Mechanism and will shortly be available for
inspection at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
Unless otherwise defined herein, capitalized terms used in this
announcement shall have the same meanings as defined in the
Circular.
Further announcements will be made in due course, as
appropriate.
Enquiries:
BSF Enterprise PLC
Geoff Baker - Executive Director
Che Connon - Managing Director
Shard Capital (Broker)
Damon Heath 0203 971 7000
Isabella Pierre 0207 1869 927
SEC Newgate (Financial Communications)
Bob Huxford 020 3757 6882
Elisabeth Cowell BSF@secnewgate.co.uk
George Esmond
For further information, please visit www.bsfenterprise.com.
LEI: 2138007PJT69H8FYLC06
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
IOEBXGDCIDDDGXL
(END) Dow Jones Newswires
September 26, 2023 09:32 ET (13:32 GMT)
Bsf Enterprise (LSE:BSFA)
Historical Stock Chart
From Nov 2024 to Dec 2024
Bsf Enterprise (LSE:BSFA)
Historical Stock Chart
From Dec 2023 to Dec 2024
